The TNM staging system and breast cancer
- 1 January 2003
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (1) , 56-60
- https://doi.org/10.1016/s1470-2045(03)00961-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis?The Lancet Oncology, 2002
- Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why?Journal of the American College of Surgeons, 2001
- Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinomaCancer, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- The voice of the breast cancer patient—a lonely cry in the wildernessEuropean Journal Of Cancer, 1997
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Time out for TNMThe Lancet, 1992
- Time to abandon TNM staging of breast cancer?The Lancet, 1992